Remagen, Germany

Friedrich W Zilliken

This inventor holds 1 USPTO granted patent. Top assignee: Zyma Sa. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Friedrich W Zilliken. Retrieved from https://idiyas.com/inventor/friedrich-w-zilliken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Friedrich W. Zilliken - Innovator in Vascular Disease Treatment

Introduction

Friedrich W. Zilliken is an accomplished inventor based in Remagen, Germany. With a focus on pharmacological innovations, he holds a significant patent that addresses the treatment of vascular diseases. Zilliken contributes his expertise at Zyma SA, where he works alongside notable colleagues.

Latest Patents

Zilliken's patent, titled "Benzopyrans and use thereof in treating vascular diseases,” focuses on Isoflavans of a specific formula. These compounds demonstrate valuable pharmacological properties, particularly in the treatment of various vascular conditions. The patent outlines methods for preparing these compounds, which are established techniques in the field.

Career Highlights

Throughout his career, Friedrich W. Zilliken has dedicated himself to advancing medical treatments through innovative research. His work at Zyma SA highlights his commitment to developing effective solutions for pressing health issues. His expertise in pharmacology and chemistry has positioned him as a vital contributor to his field.

Collaborations

Friedrich works closely with his coworker, Alban I. Albert. Their collaboration is instrumental in the development and refinement of various treatments, showcasing the importance of teamwork in the pursuit of innovative healthcare solutions.

Conclusion

Friedrich W. Zilliken's contributions to the field of vascular disease treatment through his patent serve as a testament to the impact of innovative thought in medicine. As he continues his work at Zyma SA, Zilliken remains a prominent figure in the quest for effective health advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…